A Study to Test the Interaction of Padsevonil With Oral Contraceptives in Healthy Female Participants

NCT04131517 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
14
Enrollment
INDUSTRY
Sponsor class

Stopped Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizures

Conditions

Interventions

Sponsor

UCB Biopharma SRL